TrialJournal of substance abuse treatment2022

Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.

Audun J Lier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.